SBIR/STTR Research Award

IN VITRO KIDNEY CELL CULTURE FOR NEPHROTOXIN ASSAYS

Award identifier a73ad9985cb5d51c27d5a79197fb22f98a0e0e483598c05f437c0ef1a9395522Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1992

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Biomat Corpon
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

RENAL ISCHEMIA AND POISONING OF THE KIDNEY TUBULES BY TOXIC AGENTS ARE MAJOR CAUSES OF TUBULAR NECROSIS AND ACUTE RENAL FAILURE. UNDERSTNADING THE MECHANISM OF ACTION OF DRUGS AND CHEMICALS ON RENAL CELLS IS IMPORTANT IN TOXICOLOGICAL SCREENING OF DRUGS AS WELL AS THE DEVELOPMENT CLINICAL TREATMENTS. THE GOAL OF OUR PHASE I RESEARCH PROGRAM IS TO DETERMINE THE FEASIBILITY OF USING MEMBRANES SYNTHESIZED FROM EXTRACELLULAR MATRIX COMPONENTS TO IMPROVE THE GROWTH AND DIFFERENTIATED CHARACTERISTICS OF KIDNEY CELL CULTURES AND TO EVALUATE SUITABILITY OF THESE CULTURES FOR TOXICOLOGICAL TESTING AND MECHANISTIC STUDIES. THE DEFINED SUBSTRATES WILL BE BASED ON COLLAGEN-CULTURES FOR TOXICOLOGICAL TESTING AND NECHANISTIC STUDIES. THE DEFINED SUBSTRATES WILL BE BASED ON COLLAGEN-GLYCOSAMINOGLYCAN CROSSLINKED COPOLYMERS. TWO ANIMAL SPECIES WILL BE STUDIED: RABBIT AND RAT; WORK WILL BE EXTENDED TO HUMAN CELLS IN PHASE II. SUCCESSFUL RESULTS WILL LEAD TO INCREASED LONGEVITY AND DIFFERENTIATION, PERMITTING BETTER STANDARDIZATION OF CULTURES, LONGER CONTACT TIMES FOR AGENTS TO BE TESTED, AND GREATER SENSITIVITY AND RANGE IN OBSERVING TOXIC ENDPOINTS. THE LONG-TERM OBJECTIVES OF THIS STUDY ARE CULTURES SUFFICIENTLY STABLE IN DIFFERENTIATED PROPERTIES TO BE SHIPPABLE TO THE CUSTOMER'S LABORATORY AS KITS FOR USE IN DRUG SCREENING ASSAYS, AND THE VALIDATION OF CELL CULTURE AND ASSAY SYSTEMS FOR THE ABILITY TO PREDICT HUMAN NEPHROTOXICITY.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.